Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

Lecrenier, Nicolas; Beukelaers, Pierre; Colindres, Romulo; Curran, Desmond; De Kesel, Carine; De Saegher, Jean-Philippe; Didierlaurent, Arnaud; Ledent, Edouard Y; Mols, Johann F; Mrkvan, Tomas; Normand-Bayle, Marie; Oostvogels, Lidia; Da Silva, Fernanda Tavares; Vassilev, Ventzislav; Vinals, Carlota; Brecx, Alain

doi:10.1080/14760584.2018.1495565

Scientific article

Review

English

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

ContributorsLecrenier, Nicolas; Beukelaers, Pierre; Colindres, Romulo; Curran, Desmond; De Kesel, Carine; De Saegher, Jean-Philippe; Didierlaurent, Arnaud

; Ledent, Edouard Y; Mols, Johann F; Mrkvan, Tomas; Normand-Bayle, Marie; Oostvogels, Lidia; Da Silva, Fernanda Tavares; Vassilev, Ventzislav; Vinals, Carlota; Brecx, Alain

Published inExpert Review of Vaccines, vol. 17, no. 7, p. 619-634

Publication date2018

Affiliation entities

Not a UNIGE publication

Research groups

Laboratoire d'immunologie vaccinale humaine (1025)

Citation (ISO format)

LECRENIER, Nicolas et al. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. In: Expert Review of Vaccines, 2018, vol. 17, n° 7, p. 619–634. doi: 10.1080/14760584.2018.1495565

Article (Published version)

Identifiers

PID : unige:143069
DOI : 10.1080/14760584.2018.1495565
PMID : 30028651

Commercial URLhttps://www.tandfonline.com/doi/full/10.1080/14760584.2018.1495565

Journal ISSN1476-0584

291views

1downloads

Creation12/10/2020 14:43:00

First validation12/10/2020 14:43:00

Update time15/03/2023 22:46:13

Status update15/03/2023 22:46:12

Last indexation31/10/2024 19:57:19

Archive ouverte UNIGE

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

Technical informations